Your browser doesn't support javascript.
loading
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization.
Dorbala, Sharmila; Ando, Yukio; Bokhari, Sabahat; Dispenzieri, Angela; Falk, Rodney H; Ferrari, Victor A; Fontana, Marianna; Gheysens, Olivier; Gillmore, Julian D; Glaudemans, Andor W J M; Hanna, Mazen A; Hazenberg, Bouke P C; Kristen, Arnt V; Kwong, Raymond Y; Maurer, Mathew S; Merlini, Giampaolo; Miller, Edward J; Moon, James C; Murthy, Venkatesh L; Quarta, C Cristina; Rapezzi, Claudio; Ruberg, Frederick L; Shah, Sanjiv J; Slart, Riemer H J A; Verberne, Hein J; Bourque, Jamieson M.
Afiliación
  • Dorbala S; Cardiac Amyloidosis Program, Cardiovascular Imaging Program, Departments of Radiology and Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: sdorbala@bwh.harvard.edu.
  • Ando Y; Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Bokhari S; Columbia University Medical Center, Columbia University Medical Center/New York Presbyterian Hospital, Columbia University, New York, New York.
  • Dispenzieri A; Divisions of Hematology and Cardiovascular Diseases, Department of Radiology, Division of Nuclear Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
  • Falk RH; Cardiac Amyloidosis Program, Cardiovascular Imaging Program, Departments of Radiology and Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Ferrari VA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Fontana M; Division of Medicine, National Amyloidosis Centre, University College London, London, United Kingdom.
  • Gheysens O; Nuclear Medicine and Molecular Imaging, University Hospitals Leuven, Leuven, Belgium.
  • Gillmore JD; Division of Medicine, National Amyloidosis Centre, University College London, London, United Kingdom.
  • Glaudemans AWJM; Medical Imaging Center, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Hanna MA; Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.
  • Hazenberg BPC; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Kristen AV; Department of Cardiology, University of Heidelberg, Heidelberg, Germany.
  • Kwong RY; Cardiac Amyloidosis Program, Cardiovascular Imaging Program, Departments of Radiology and Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Maurer MS; Columbia University Medical Center, Columbia University Medical Center/New York Presbyterian Hospital, Columbia University, New York, New York.
  • Merlini G; Amyloidosis Research and Treatment Center, Foundation Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Miller EJ; Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut.
  • Moon JC; Division of Medicine, National Amyloidosis Centre, University College London, London, United Kingdom.
  • Murthy VL; Frankel Cardiovascular Center, Michigan Medicine, Ann Arbor, Michigan.
  • Quarta CC; Division of Medicine, National Amyloidosis Centre, University College London, London, United Kingdom.
  • Rapezzi C; Cardiology Unit, Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater-University of Bologna, Bologna, Italy.
  • Ruberg FL; Amyloidosis Center and Section of Cardiovascular Medicine, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, Massachusetts.
  • Shah SJ; Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
  • Slart RHJA; Medical Imaging Center, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Verberne HJ; Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Bourque JM; Cardiovascular Imaging Center, Departments of Medicine and Radiology, University of Virginia, Charlottesville, Virginia.
J Card Fail ; 25(11): 854-865, 2019 Nov.
Article en En | MEDLINE | ID: mdl-31473267
ABSTRACT
Cardiac amyloidosis is emerging as an underdiagnosed cause of heart failure and mortality. Growing literature suggests that a noninvasive diagnosis of cardiac amyloidosis is now feasible. However, the diagnostic criteria and utilization of imaging in cardiac amyloidosis are not standardized. In this paper, Part 2 of a series, a panel of international experts from multiple societies define the diagnostic criteria for cardiac amyloidosis and appropriate utilization of echocardiography, cardiovascular magnetic resonance imaging, and radionuclide imaging in the evaluation of patients with known or suspected cardiac amyloidosis.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sociedades Médicas / Cardiología / Imagen Multimodal / American Heart Association / Amiloidosis / Cardiomiopatías Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: J Card Fail Asunto de la revista: CARDIOLOGIA Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sociedades Médicas / Cardiología / Imagen Multimodal / American Heart Association / Amiloidosis / Cardiomiopatías Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: J Card Fail Asunto de la revista: CARDIOLOGIA Año: 2019 Tipo del documento: Article